Betashell Eye Drops contain Betaxolol 0.5% w/v, a selective beta-blocker used for reducing elevated intraocular pressure in patients with glaucoma and ocular hypertension. Its precise formulation ensures safe and effective long-term ophthalmic management.
The eye drop works by decreasing aqueous humor production, helping to control eye pressure and prevent optic nerve damage, while maintaining good patient tolerance during prolonged therapy.
From a business perspective, Betashell Eye Drops are a high-demand anti-glaucoma ophthalmic product, commonly prescribed in eye hospitals, specialty clinics, and ophthalmology centers, ensuring consistent sales and repeat prescriptions.
Adding Betashell Eye Drops to your portfolio strengthens the ophthalmic anti-glaucoma segment, offering long-term market stability, strong prescriber confidence, and enhanced portfolio credibility for pharma franchise partners.
Common side effects may include mild burning or stinging sensation, eye discomfort, blurred vision, or dryness of eyes. Rarely, systemic effects such as slow heart rate, fatigue, dizziness, or breathing difficulty may occur, especially in susceptible patients.
Betashell Eye Drops are indicated for the management of open-angle glaucoma and ocular hypertension. They are used to reduce elevated intraocular pressure and help prevent progression of optic nerve damage under ophthalmologist supervision.
Use Betashell Eye Drops strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Use caution in patients with cardiac or respiratory conditions. Discontinue use and seek medical advice if severe eye irritation, vision changes, or systemic symptoms occur.
Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use after the expiry date.